CMS: States Could Keep Providers From Using 340B Drugs In Medicaid

CMS suggested as part of new guidance laying out ways to avoid duplicate discounts between 340B and Medicaid that states could use state plan amendments to keep some -- or all -- providers and contract pharmacies from using 340B drugs for Medicaid beneficiaries, and 340B hospitals quickly pushed back. “[W]e are extremely troubled by the inclusion of language that would allow states to limit the ability of some or all 340B hospitals and contract pharmacies to use 340B purchased drugs...